On the other hand it has been reported that TGF-β reduced PLC/PRF/5 cell proliferation in vitro and that a low expression of TGF-βRII in HCC tissues was correlated with a more aggressive disease [11]. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.